サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477115

異種移植市場：製品別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Xenotransplantation Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 289 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
異種移植市場：製品別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年04月25日
発行: AnalystView Market Insights
ページ情報: 英文 289 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

異種移植市場規模は2023年に133億510万米ドルとなり、2024年から2032年にかけてCAGR 10.2％で拡大

異種移植市場-市場力学

組織・臓器移植のニーズの高まり

異種移植は、移植用の臓器や組織の代替供給源となる可能性があります。移植用のヒト臓器・組織の不足が、移植を必要とする患者の長い待機リストと高い死亡率につながっていることを考えると、これは特に重要です。異種移植技術の開発には多大な研究と技術革新が必要であり、それは他の医学分野の進歩にもつながります。世界保健機関（WHO）は、異種移植には移植片の細胞や組織による感染の潜在的リスクがあるとして、ドナーの臨床試験に関する規制を定めています。臨床試験がないため、リスクの程度は不明です。

異種移植市場-主要インサイト

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約10.2%のCAGRで毎年成長すると予測されています。

用途別では、臓器移植は2023年に最大の市場シェアを示すと予測されました。

エンドユーザー別では、病院・診療所が2023年の主要タイプでした。

地域別では、北米が2023年に主要な収益源となった。

異種移植市場-セグメンテーション分析：

世界の異種移植市場は、製品、用途、エンドユーザー、地域によって区分されます。

市場は用途別に5つに分類される：異種移植は、臓器や組織をある種から別の種に移植するプロセスであり、移植用のヒト臓器の危機的な不足に対処する可能性を秘めています。異種移植は、臓器の代替供給源を提供し、不足しがちな移植用のヒト臓器の依存を軽減する可能性があります。

同市場は、エンドユーザー別に以下の3つのカテゴリーに分類される：異種移植は、解剖学的・生理学的にヒトと類似しているブタなどの動物の臓器を使用することで、移植用のヒト臓器の不足に対処することができます。これにより、臓器移植を待つ患者の命を救える可能性があります。異種移植は、組織の再生や修復のための生物学的足場やマトリックスを作る組織工学にも利用できます。

異種移植市場-地理的洞察

北米は、医療分野での進歩が著しく、臓器不全の症例数が増加していることから、異種移植市場において主導的地位を占めています。同地域は、既存のインフラ、研究スキル、ヘルスケアへの投資により、異種移植のような最先端の医療技術の開発と応用において主導権を握ることができます。さらに、アジア太平洋地域の人口増加により、ヘルスケアサービス、特に異種移植に対するニーズが高まっています。

異種移植市場-競合情勢：

異種移植市場には、バイオテクノロジー企業、製薬企業、学術機関、調査機関など、さまざまな企業が参入しています。その中には、Preservation Solutions、OrganOX Limited、B. Braun Medical Institute、Terumo Medical Corporation、Roche、Astellas Pharma、Sino-Clone Organ Biotechnologyなどの大手企業が含まれています。例えば、イージェネシスは遺伝子編集技術を用いた異種移植ソリューションの開発に注力しているバイオテクノロジー企業です。ブタの臓器をヒトに適合させるための遺伝子組み換えで知られています。これらの企業は、異種移植技術を進歩させ、市場に投入するための研究、開発、商業化の取り組みに積極的に関与しています。例えば、2024年3月、マサチューセッツ総合病院で、生きたレシピエントへの世界初の遺伝子組み換えブタの腎臓移植が行われました。

目次

第1章 異種移植市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 異種移植の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 異種移植産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 異種移植市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 異種移植市場情勢

  • 異種移植市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 異種移植市場- 製品別

  • 概要
    • 製品別セグメントシェア分析
    • 臓器保存
    • 移植診断
    • 組織
    • ゼノ製品
      • 器官
      • 細胞
      • 組織
    • その他

第8章 異種移植市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 心臓病学
    • 神経学
    • 糖尿病
    • 臓器移植
    • 再生医療

第9章 異種移植市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院と診療所
    • 調査機関および研究所
    • バイオテクノロジーおよび製薬企業

第10章 異種移植市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 異種移植業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Terumo Medical Corporation
    • Transonic
    • F. Hoffmann-La Roche Ltd.
    • Astellas Pharma, Inc.
    • Preservation Solutions, Inc.
    • OrganOX Limited
    • Bio Med Pvt. Ltd.
    • Transplant Biomedical
    • TransMedic, Pte. Ltd.
    • Novartis AG
    • Organ Recovery Systems
    • Accord Healthcare
    • Pfizer, Inc
    • Veloxis Pharmaceuticals, Inc.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Xenotransplantation Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Xenotransplantation Market, by Product 2019-2032 (USD Million)
  • TABLE Xenotransplantation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Xenotransplantation Market, by Application 2019-2032 (USD Million)
  • TABLE Xenotransplantation Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Xenotransplantation Market, by End User 2019-2032 (USD Million)
  • TABLE Xenotransplantation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Xenotransplantation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Xenotransplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Xenotransplantation Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Xenotransplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Xenotransplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Xenotransplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Xenotransplantation Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Xenotransplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Xenotransplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Xenotransplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Xenotransplantation Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Xenotransplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Xenotransplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Xenotransplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Xenotransplantation Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Xenotransplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Xenotransplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Xenotransplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Xenotransplantation Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Xenotransplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Xenotransplantation Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2511

REPORT HIGHLIGHT

Xenotransplantation Market size was valued at USD 13,305.1 Million in 2023, expanding at a CAGR of 10.2% from 2024 to 2032.

Xenotransplantation is the process of transplanting living cells, tissues, or organs from one species to another. It typically refers to transplanting organs or tissues from animals into humans. The rising incidence of organ failure due to factors like aging populations, lifestyle diseases, and chronic conditions increases the demand for alternative transplant options. However, the risk of immune rejection and transmission of infectious diseases from the donor animal to the recipient poses significant challenges to the widespread adoption of xenotransplantation. Moreover, advances in gene editing technologies like CRISPR/Cas9 offer opportunities to address immunological barriers and potentially expanding the pool of transplantable organs.

Xenotransplantation Market- Market Dynamics

Increasing need for tissue and organ transplantation

Xenotransplantation could potentially provide an alternative source of organs and tissues for transplantation, thereby expanding the supply beyond what is available from human donors. This is particularly important given the shortage of human organs and tissues for transplantation, leading to long waiting lists and high mortality rates for patients in need. The development of xenotransplantation technologies requires significant research and innovation, which can also lead to advancements in other areas of medicine. World Health Organization (WHO) have set regulations for clinical trials of a donor as xenotransplantation carries the potential risk of the transmission of infection with the cells or tissues of the graft. The degree of risk is unknown in the absence of clinical trials.

Xenotransplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.2% over the forecast period (2024-2032)

Based on application segmentation, organ transplantation was predicted to show maximum market share in the year 2023

Based on end users segmentation, hospitals & clinics was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Xenotransplantation Market- Segmentation Analysis:

The Global Xenotransplantation Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into five categories based on application: Xenotransplantation, the process of transplanting organs or tissues from one species to another, has the potential to address the critical shortage of human organs for transplantation. Xenotransplantation could provide an alternative source of organs, reducing the dependency on human donors, which are often in short supply.

The market is categorized into three categories based on end user: : Xenotransplantation could address the shortage of human organs for transplantation by using organs from animals, such as pigs, which have anatomical and physiological similarities to humans. This could potentially save the lives of patients awaiting organ transplants. Xenotransplantation can be used in tissue engineering to create biological scaffolds or matrices for tissue regeneration and repair.

Xenotransplantation Market- Geographical Insights

North America's strong progress in the medical field and the growing number of organ failure cases contribute to the region's leadership in the xenotransplantation market. The region is equipped to take the lead in the development and application of cutting-edge medical technologies like xenotransplantation because of its existing infrastructure, research skills, and healthcare investments. Additionally, the growing population in the Asia-Pacific region raises the need for healthcare services, particularly xenotransplantation.

Xenotransplantation Market- Competitive Landscape:

Xenotransplantation market involves various players including biotechnology companies, pharmaceutical companies, academic institutions, and research organizations. Several of the leading companies in the "Global Xenotransplantation Market" are included in it, including Preservation Solutions, OrganOX Limited, B. Braun Medical Institute, Terumo Medical Corporation, Roche, Astellas Pharma, and Sino-Clone Organ Biotechnology. For instance, eGenesis is a biotechnology company focused on using gene editing technologies to develop xenotransplantation solutions. They are known for their work in genetically modifying pigs to make their organs more compatible with humans. These companies are actively involved in research, development, and commercialization efforts to advance xenotransplantation technologies and bring them to market. For instance, in March 2024, world's first genetically-edited pig kidney transplant into living recipient performed at massachusetts general hospital.

Recent Developments:

In April 2024, United Therapeutics Corporation, a public benefit corporation, announced the world's first successful transplant of a UThymoKidney, which the company produced, into a living person. This transplant represents several historic firsts for transplantation:

In March 2023, Johns Hopkins Medicine received $21.4 million to advance viability of animal organs for transplants and enable human clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL XENOTRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Terumo Medical Corporation

Transonic

F. Hoffmann-La Roche Ltd.

Astellas Pharma, Inc.

Preservation Solutions, Inc.

OrganOX Limited

Bio Med Pvt. Ltd.

Transplant Biomedical

TransMedic, Pte. Ltd.

Novartis AG

Organ Recovery Systems

Accord Healthcare

Pfizer, Inc

Veloxis Pharmaceuticals, Inc.

Others

GLOBAL XENOTRANSPLANTATION MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Organ Preservation Solutions
  • Transplant Diagnostics
  • Tissue Products
  • Xeno Products
  • Organ
  • Cell
  • Tissue
  • Others

GLOBAL XENOTRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiology
  • Neurology
  • Diabetes
  • Organ Transplantation
  • Regenerative Medicine

GLOBAL XENOTRANSPLANTATION MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Research Institutes and Laboratories
  • Biotechnology and Pharmaceutical Companies

GLOBAL XENOTRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Xenotransplantation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Xenotransplantation Market Snippet by Product
    • 2.1.2. Xenotransplantation Market Snippet by Application
    • 2.1.3. Xenotransplantation Market Snippet by End User
    • 2.1.4. Xenotransplantation Market Snippet by Country
    • 2.1.5. Xenotransplantation Market Snippet by Region
  • 2.2. Competitive Insights

3. Xenotransplantation Key Market Trends

  • 3.1. Xenotransplantation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Xenotransplantation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Xenotransplantation Market Opportunities
  • 3.4. Xenotransplantation Market Future Trends

4. Xenotransplantation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Xenotransplantation Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Xenotransplantation Market Landscape

  • 6.1. Xenotransplantation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Xenotransplantation Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Organ Preservation Solutions
    • 7.1.3. Transplant Diagnostics
    • 7.1.4. Tissue Products
    • 7.1.5. Xeno Products
      • 7.1.5.1. Organ
      • 7.1.5.2. Cell
      • 7.1.5.3. Tissue
    • 7.1.6. Others

8. Xenotransplantation Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Cardiology
    • 8.1.3. Neurology
    • 8.1.4. Diabetes
    • 8.1.5. Organ Transplantation
    • 8.1.6. Regenerative Medicine

9. Xenotransplantation Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Research Institutes and Laboratories
    • 9.1.4. Biotechnology and Pharmaceutical Companies

10. Xenotransplantation Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Xenotransplantation Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Xenotransplantation Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Xenotransplantation Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Xenotransplantation Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Xenotransplantation Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Xenotransplantation Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Terumo Medical Corporation
    • 11.2.2. Transonic
    • 11.2.3. F. Hoffmann-La Roche Ltd.
    • 11.2.4. Astellas Pharma, Inc.
    • 11.2.5. Preservation Solutions, Inc.
    • 11.2.6. OrganOX Limited
    • 11.2.7. Bio Med Pvt. Ltd.
    • 11.2.8. Transplant Biomedical
    • 11.2.9. TransMedic, Pte. Ltd.
    • 11.2.10. Novartis AG
    • 11.2.11. Organ Recovery Systems
    • 11.2.12. Accord Healthcare
    • 11.2.13. Pfizer, Inc
    • 11.2.14. Veloxis Pharmaceuticals, Inc.
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us